Your browser doesn't support javascript.
loading
Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome.
Thakolwiboon, Smathorn; Linnoila, Jenny; Pittock, Sean J; Dubey, Divyanshu; Zekeridou, Anastasia.
Afiliação
  • Thakolwiboon S; Department of Neurology, Mayo Clinic, Rochester, MN, United States of America; Department of Neurology, Mayo Clinic Health System Franciscan Health Care, La Crosse, WI, United States of America; Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, United States of America. Electronic
  • Linnoila J; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States of America. Electronic address: linnoila.jenny@mgh.harvard.edu.
  • Pittock SJ; Department of Neurology, Mayo Clinic, Rochester, MN, United States of America; Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: pitt
  • Dubey D; Department of Neurology, Mayo Clinic, Rochester, MN, United States of America; Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: dube
  • Zekeridou A; Department of Neurology, Mayo Clinic, Rochester, MN, United States of America; Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: zeke
J Neuroimmunol ; 387: 578293, 2024 02 15.
Article em En | MEDLINE | ID: mdl-38266443
ABSTRACT
Purkinje cell cytoplasmic autoantibody type 1 (PCA1), also known as anti-Yo, is a 'high-risk' paraneoplastic antibody, associated with rapidly progressive cerebellar syndrome. In patients with this syndrome, various MRI abnormalities have been documented, including atrophy in the cerebellum and brainstem, T2 hyperintensity in the brainstem and spinal cord, and cranial nerve enhancement. This report introduces an imaging finding, cerebellar leptomeningeal enhancement, which was observed in all three cases at early stages. Despite neurological deterioration, all patients underwent immunotherapy, and subsequent follow-up MRI revealed resolution of the leptomeningeal enhancement, suggesting that this feature is distinct from meningeal carcinomatosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Paraneoplásicas / Doenças Cerebelares / Degeneração Paraneoplásica Cerebelar Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Paraneoplásicas / Doenças Cerebelares / Degeneração Paraneoplásica Cerebelar Idioma: En Ano de publicação: 2024 Tipo de documento: Article